Navigation Links
Argonne, University of Chicago scientists develop targeted cancer treatment using nanomaterials
Date:8/19/2009

ARGONNE, Ill. (Aug. 19, 2009) Scientists from the U.S. Department of Energy's (DOE) Argonne National Laboratory and the University of Chicago's Brain Tumor Center have developed a way to target brain cancer cells using inorganic titanium dioxide nanoparticles bonded to soft biological material.

Thousands of people die from malignant brain tumors every year, and the tumors are resistant to conventional therapies. This nano-bio technology may eventually provide an alternative form of therapy that targets only cancer cells and does not affect normal living tissue.

"It is a real example of how nano and biological interfacing can be used for biomedical application," said scientist Elena Rozhkova with Argonne's Center for Nanoscale Materials. "We chose brain cancer because of its difficulty in treatment and its unique receptors."

This new therapy relies on a two-pronged approach. Titanium dioxide is a versatile photoreactive nanomaterial that can be bonded with biomolecules. When linked to an antibody nanoparticles recognize and bind specifically to cancer cells. Focused visible light is shined onto the affected region, and the localized titanium dioxide reacts to the light by creating free oxygen radicals that interact with the mitochondria in the cancer cells. Mitochondria act as cellular energy plants, and when free radicals interfere with their biochemical pathways, mitochondria receive a signal to start cell death.

"The significance of this work lies in our ability to effectively target nanoparticles to specific cell surface receptors expressed on brain cancer cells," said Dr. Maciej S. Lesniak, Director of Neurosurgical Oncology at University of Chicago Brain Tumor Center. "In so doing, we have overcome a major limitation involving the application of nanoparticles in medicine, namely the potential of these agents to distribute throughout the body. We are now in a position to develop this exciting technology in preclinical
'/>"/>

Contact: Brock Cooper
bcooper@anl.gov
630-252-5565
DOE/Argonne National Laboratory
Source:Eurekalert

Page: 1 2

Related medicine news :

1. University of Iowa professor identifies new eating disorder
2. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
3. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
4. Tulane University to receive $14M for international HIV/AIDS program
5. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
6. Boston University School of Medicine researcher recipient of Memory Ride Grant
7. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
8. Medina General Hospital and University Hospitals Agree to Pursue Affiliation
9. J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas
10. The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers
11. George Mason University professor receives $2.6 million NIH grant to study Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... Izenda is proud to acknowledge ... currently attending an accredited American educational institution through its scholarship program. , In ... healthcare, the environment, political campaigns, and a variety of other worldwide trends. Modern ...
(Date:6/30/2015)... ... 2015 , ... Americans report feeling more stressed than ever before. There’s even ... stressed out people right over the edge. , Almost half of Americans report ... night. Sleeping pills now lead the list of the most prescribed medications, despite reported ...
(Date:6/30/2015)... ... June 30, 2015 , ... Scott Purdy, the spokesperson for Dephinitive Systems LLC, ... Purdy stated that the XO stands for eXtra Operability (XO) which was chosen to ... of the Revenue Cycle. , Provider XO, based in Cleveland OH, is part ...
(Date:6/30/2015)... , ... June 30, 2015 , ... “It is never ... of SunGrubbies.com. “We are particularly interested in getting the word out to children ... to surface. We are extremely pleased with our new video which we ...
(Date:6/29/2015)... ... 30, 2015 , ... Sublime Beauty NATURALS® introduces its new USDA Certified Organic ... for natural skincare and even culinary uses, was especially designed for Oil Pulling. ... and Oil Pulling can accomplish this. Oil Pulling is an Ayurvedic practice that is ...
Breaking Medicine News(10 mins):Health News:Izenda Offers Embedded BI and Analytics Scholarship 2Health News:Izenda Offers Embedded BI and Analytics Scholarship 3Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 2Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 3Health News:Dephinitive Systems Is Getting a New Name 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 3Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2
... 13 The American Association of Homes and ... than 60 aging and disability organizations to urge ... a part of health care reform legislation.The groups ... Call today and on a Congressional call-in ...
... CINCINNATI, May 13, 2009 Today, the United States ... favor of The Procter & Gamble Company (P&G) in ... Pharmaceuticals USA, Inc. The positive ruling protects P&G,s ... therapy Actonel(R) (risedronate sodium) tablets. Actonel is commercialized ...
... Irvine, Calif., May 13, 2009 A potential vaccine ... to slow the weakening of muscles associated with inclusion ... The finding brings new hope for IBM patients with ... wrists, forearms or quadriceps. There is no cure for ...
... 2009 Orange County Arthritis Walk(R)IRVINE, Calif., May 13 ... the Arthritis Foundation. The Orange County Great Park ... County Arthritis Walk(R) set to take place on Sunday, ... Foundation,s annual nationwide event to raise funds for arthritis ...
... The decision by the Centers for ... colonography, also known as "virtual" colonoscopy, a radiographic examination ... on the test,s potential as an appropriate option for ... of the primary issues identified by CMS is that ...
... 13 At a congressional hearing today in Washington, ... of Veterans Affairs to immediately expand use of ViziLite(R) ... oral abnormalities that could lead to cancer. David Bethune, ... ZILA ), developer and marketer of ViziLite Plus, addressed ...
Cached Medicine News:Health News:AAHSA Joins Sixty Aging and Disability Groups to Fight for Long-Term Services and Supports in Health Care Reform 2Health News:Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel 2Health News:Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel 3Health News:Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel 4Health News:Vaccine slows progression of skeletal muscle disorder 2Health News:Take a Walk in the Great Park to Benefit the Arthritis Foundation 2Health News:Decision by Medicare's CMS to Deny Coverage for 'Virtual' Colon Cancer Tests Underscores Lack of Evidence on Cancer Prevention 2Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 2Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 3Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 4Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 5Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 6Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 7
(Date:6/29/2015)... , June 29, 2015 BiondVax ... preliminary results from its BVX-006 Phase II clinical trial ... In this trial, M-001 was injected intramuscularly to volunteers ... an administration of the 2014/15 season trivalent influenza vaccine ... safe and well tolerated and induced humoral immune responses, ...
(Date:6/29/2015)... 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... Russell 1000 Index, effective June 26, 2015. The Russell ... of the U.S. equity universe. It is a subset ... of the largest securities based on a combination of ... "We are pleased to be added to this important ...
(Date:6/29/2015)... SAN JOSE, Calif. , June 29, 2015 ... its expert medical workstation lineup. The high-powered, multi-functional ... th generation Intel® Haswell Core ... processor. Both provide significant data processing and computing ... visual performance, making the unit well suited for ...
Breaking Medicine Technology:BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... curtains or parting strip shields ... frame to form a free-standing, ... cleanliness to Class 10/ISO 3. ... lights, and ionizers are configured ...
Inquire...
Inquire...
Inquire...
Medicine Products: